Why US-EU trade deal faces jeopardy over ambiguous pharmaceutical tariffs

Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement. Analysts caution that sector-specific punitive levies could jeopardise the entire deal, according to a CNBC report. Significant ambiguity surrounds the precise definitions and classifications of pharmaceutical goods within the framework of the trade truce finalised on Sunday. This agreement introduces a […]
|
||||||
|
||||||
|
||||||
You Might LikeRelated videos from verified sources
|